New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 26, 2012
06:45 EDTAEGRAegerion price target raised to $30 from $25 at Leerink
Leerink raised its price target for Aegerion after the FDA approved Juxtapid. The firm reiterates an Outperform rating on Aegerion, noting the company obtained the broadest possible label possible for Juxtapid.
News For AEGR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 18, 2014
17:17 EDTAEGRIntegrated Core Strategies reports 5.1% passive stake in Aegerion
Subscribe for More Information
November 12, 2014
08:13 EDTAEGRBoston Biotech to hold a conference
Subscribe for More Information
November 11, 2014
08:53 EDTAEGRAegerion says SEC issues request for information to specialty pharmacy entity
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use